Today's IPO for Treace Medical Concepts, Inc. (NASDAQ: TMCI) opened for trading at $24.50 after pricing 11,250,000 shares of its common stock, 6,250,000 of which are being sold by Treace and 5,000,000 of which are being sold by certain selling stockholders, at a public offering price of $17.00 per share.

J.P. Morgan and Morgan Stanley are acting as joint book-running managers for the offering. SVB Leerink and Stifel are acting as co-managers for the offering.

Treace Medical Concepts, Inc. (Treace) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions